Nuveen Asset Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-45,568
| Closed | -$6M | – | 3333 |
|
|
2020
Q4 | $6M | Buy |
45,568
+1,556
| +4% | +$205K | ﹤0.01% | 1974 |
|
|
2020
Q3 | $2.22M | Sell |
44,012
-5,387
| -11% | -$272K | ﹤0.01% | 2329 |
|
|
2020
Q2 | $2.36M | Sell |
49,399
-8,218
| -14% | -$392K | ﹤0.01% | 2270 |
|
|
2020
Q1 | $2.82M | Buy |
57,617
+2,524
| +5% | +$124K | ﹤0.01% | 2024 |
|
|
2019
Q4 | $3.16M | Sell |
55,093
-2,593
| -4% | -$149K | ﹤0.01% | 2228 |
|
|
2019
Q3 | $2.08M | Buy |
57,686
+16,280
| +39% | +$586K | ﹤0.01% | 2379 |
|
|
2019
Q2 | $1.29M | Buy |
+41,406
| New | +$1.29M | ﹤0.01% | 2634 |
|